Q4 Resuts: Biocon’s Profit Meets Estimates Buoyed By  Strong Growth In Biologics Unit
An employee in protective clothing arranges samples inside the R&D centre at the Biocon Ltd. campus in Bengaluru. (Photographer: Dhiraj Singh/Bloomberg)

Q4 Resuts: Biocon’s Profit Meets Estimates Buoyed By Strong Growth In Biologics Unit

Bookmark
Biocon Ltd.’s profit for the March quarter beat estimates due to strong growth in its biologics business.Biocon’s three main businesses—biologics, small molecules and research services—grew at 87 p...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.